0001179110-19-011139.txt : 20191021
0001179110-19-011139.hdr.sgml : 20191021
20191021163356
ACCESSION NUMBER: 0001179110-19-011139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191017
FILED AS OF DATE: 20191021
DATE AS OF CHANGE: 20191021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hurley Ariel
CENTRAL INDEX KEY: 0001769740
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 191159847
MAIL ADDRESS:
STREET 1: C/O BLUEPRINT MEDICINES CORPORATION
STREET 2: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2019-10-17
0
0001597264
Blueprint Medicines Corp
BPMC
0001769740
Hurley Ariel
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Principal Accounting Officer
Common Stock
2019-10-17
4
M
0
415
1.87
A
415
D
Common Stock
2019-10-17
4
S
0
415
75
D
0
D
Stock Option (Right to Buy)
1.87
2019-10-17
4
M
0
415
0
D
2024-10-08
Common Stock
415
12184
D
Effected pursuant to a trading plan adopted on December 17, 2018 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This option was granted on October 8, 2014. This option vested with respect to 25% of the shares underlying the option on September 15, 2015 and vested as to an additional 1/48th of the shares underlying the option each month thereafter.
/s/ Christopher Frankenfield, Attorney-in-Fact
2019-10-21